Abstract
Pharmaceuticals are nothing more than chemicals (which may or may not be produced by biotechnological techniques) having a certain physiological effect. In general therefore pharmaceutical patent issues are a special case of those relating to chemical patents, particularly in relation to claims to ‘Novel Chemical Entities’ (NCEs—chemical compounds that were not previously known) and processes. This chapter discusses a number of chemical patent issues, but with specific reference to pharmaceuticals. There are, however, also a number of aspects of patent law which are specific to pharmaceuticals and not to other chemicals and some of these relate also to medical devices. These largely find their basis in certain public policy concerns and in the regulatory framework affecting pharmaceuticals. Such issues are discussed in the next chapter.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Copyright information
© 1991 Bird & Bird
About this chapter
Cite this chapter
Cook, T., Doyle, C., Jabbari, D. (1991). Patents for Chemicals. In: Pharmaceuticals, Biotechnology & the Law. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-21828-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-349-21828-8_4
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-21830-1
Online ISBN: 978-1-349-21828-8
eBook Packages: Palgrave Political & Intern. Studies CollectionPolitical Science and International Studies (R0)